An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Amneal to Participate at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its participation in two upcoming investor conferences. The Piper Sandler 34th Annual Healthcare Conference will be held on December 1, 2022 in New York, while the 41st Annual J.P. Morgan Healthcare Conference is scheduled for January 10, 2023 in San Francisco, with a presentation at 2:15 PM PT. A live webcast of the J.P. Morgan presentation will be available on the company's website, with a replay accessible for 90 days.
Amneal is a fully integrated essential medicines company based in Bridgewater, NJ, focusing on generic and specialty pharmaceuticals.
Positive
None.
Negative
None.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that the management team will attend the following investor conferences:
Piper Sandler 34th Annual Healthcare Conference
December 1, 2022 New York, New York
41st Annual J.P. Morgan Healthcare Conference January 10, 2023 San Francisco, California Presentation – 2:15 PM Pacific Time
A live webcast of the J.P. Morgan Healthcare conference presentation will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. A replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the United States. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across a broad range of complex products and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceutical products focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more, please visit www.amneal.com.
What investor conferences will Amneal Pharmaceuticals attend?
Amneal Pharmaceuticals will attend the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022, and the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023.
When is Amneal's presentation at the J.P. Morgan Healthcare Conference?
Amneal's presentation at the J.P. Morgan Healthcare Conference is scheduled for January 10, 2023, at 2:15 PM Pacific Time.
Where can I watch the live webcast of Amneal's presentation?
The live webcast of Amneal's presentation can be accessed through the Investor Relations section of their website.
How long will the replay of Amneal's webcast be available?
The replay of Amneal's webcast will be available for 90 days after the event.
What is Amneal Pharmaceuticals known for?
Amneal Pharmaceuticals is known for developing, manufacturing, and distributing generic and specialty pharmaceuticals, with a focus on essential medicines.
